New IDC Survey Shows Shift in Software Pricing and Purchasing Trends - More to Be Revealed at Upcoming IDC Briefings

New IDC Survey Shows Shift in Software Pricing and Purchasing Trends - More to Be Revealed at Upcoming IDC Briefings

04 Jun 2009

FRAMINGHAM, Mass., June 4, 2009 - A recent IDC survey of IT and line of business (LOB) professionals shows that more than 60% of respondents believe that now is a good time to negotiate steep discounts for traditional on-premise software.

"In this economy, traditional licensing approaches are under fire, with steep license discounts and maintenance concessions the norm," said Amy Konary, program director, Software Pricing, Licensing, and Delivery. "In order to survive the downturn and position for growth in an eventual recovery, software companies will have to evolve their go-to-market approach, and subscription pricing and SaaS will play a key role."

This IDC survey also showed that organizations are highly interested in software pricing options that help shift spending from capital budgets to operating budgets. Additionally, more than half of C-Level executives surveyed are open to buying software from a small firm with a very short track record, if the price is good and functionality seems at least comparable.

A further discussion of the results of this survey, as well as an update on the growth expectations for SaaS and subscription, will be presented at two upcoming IDC Briefings -- Going Hybrid with SaaS - Managing Perpetual and Subscription Businesses In the Same Chassis. These events will highlight the key characteristics that customers are looking for in the pricing of software offerings based on the results of this April 2009 SaaS pricing survey. The East Coast event will be held on June 9, 2009 in Framingham, Mass. and the West Coast event will be held on June 17, 2009 in Burlingame, Calif. For more information contact Melissa Bambauer at [email protected]

This research was delivered via IDC's Enterprise Panel (IEP). The panel is comprised primarily of U.S. respondents, and consists of both IT and LOB executives.

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.